Protective role of leukotriene B4 receptor type 2 in acute lung injury
Project/Area Number |
15H06604
|
Research Category |
Grant-in-Aid for Research Activity Start-up
|
Allocation Type | Single-year Grants |
Research Field |
Anesthesiology
|
Research Institution | Juntendo University |
Principal Investigator |
Shigematsu Misako 順天堂大学, 医学(系)研究科(研究院), 非常勤助手 (60760303)
|
Project Period (FY) |
2015-08-28 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | 急性肺傷害 / 脂質受容体 / ロイコトリエン / ニューモライシン / モンテルカスト / 脂質 / 感染症 |
Outline of Final Research Achievements |
In this study we explored the roles of leukotriene B4 receptor type 2 (BLT2) in the lung using an acute lung injury model induced by a pneumococcal toxin, pneumolysin (PLY). BLT2 signaling plays important role in protecting against the PLY-induced acute lung injury by suppressing cysteinyl leukotrienes receptor (CysLT1) expression in lung endothelial cells, and by attenuating the susceptibility to PLY-dependently produced cysteinyl leukotrienes. Additionally, CysLT1 antagonists that currently used as anti-asthmatic drugs will be beneficial to treat acute lung injury in the early phase of pneumococcal pneumonia.
|
Report
(3 results)
Research Products
(11 results)
-
-
-
[Journal Article] Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury2016
Author(s)
Shigematsu, M., Koga, T., Ishimori, A., Saeki, K., Ishii, Y., Taketomi, Y., Ohba, M., Jo-Watanabe, A., Okuno, T., Harada, N., Harayama, T., Shindou, H., Li, J. D., Murakami, M., Hoka, S.,Yokomizo, T.
-
Journal Title
Sci Rep
Volume: 6
Issue: 1
Pages: 34560-34560
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
-
-
-
-